Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?

Diabetes Care ◽

10.2337/dc20-0913 ◽

2021 ◽

Vol 44 (3) ◽

pp. 641-646

Author(s):

Ele Ferrannini ◽

Julio Rosenstock

Keyword(s):

Type 2 Diabetes ◽

Clinical Translation ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646

Diabetes Care ◽

10.2337/dci21-0014 ◽

2021 ◽

pp. dci210014

Author(s):

Ele Ferrannini ◽

Julio Rosenstock

Keyword(s):

Type 2 Diabetes ◽

Diabetes Care ◽

Clinical Translation ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641–646

Diabetes Care ◽

10.2337/dc21-0518 ◽

2021 ◽

pp. dc210518

Author(s):

Stavros Liatis

Keyword(s):

Type 2 Diabetes ◽

Diabetes Care ◽

Clinical Translation ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2031;44:641–646

Diabetes Care ◽

10.2337/dc21-er06 ◽

2021 ◽

pp. dc21er06

Author(s):

Ele Ferrannini ◽

Julio Rosenstock

Keyword(s):

Type 2 Diabetes ◽

Diabetes Care ◽

Clinical Translation ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Cardiovascular Outcome Trials ◽

Download Full-text

Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A Meta-analysis of Cardiovascular Outcome Trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108648 ◽

2021 ◽

pp. 108648

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus

Statistics in Biopharmaceutical Research ◽

10.1080/19466315.2017.1280411 ◽

2017 ◽

Vol 9 (4) ◽

pp. 347-360 ◽

Author(s):

Olga Marchenko ◽

Qi Jiang ◽

Christy Chuang-Stein ◽

Cyrus Mehta ◽

Mark Levenson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Diabetes Therapy ◽

10.1007/s13300-019-00701-3 ◽

2019 ◽

Vol 10 (6) ◽

pp. 2153-2167 ◽

Author(s):

Mafalda Ramos ◽

Volker Foos ◽

Anastasia Ustyugova ◽

Nikco Hau ◽

Pranav Gandhi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Effectiveness Analysis

Download Full-text

Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.011 ◽

2020 ◽

Vol 44 (1) ◽

pp. 68-77 ◽

Author(s):

Elodie M. Varin ◽

Brent A. McLean ◽

Julie A. Lovshin

Keyword(s):

Type 2 Diabetes ◽

Adult Patients ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK

Diabetic Medicine ◽

10.1111/dme.14058 ◽

2019 ◽

Vol 36 (9) ◽

pp. 1063-1071 ◽

Author(s):

S. C. Bain ◽

A. Bakhai ◽

M. Evans ◽

A. Green ◽

I. Menown ◽

...

Keyword(s):

Type 2 Diabetes ◽

Pharmacological Treatment ◽

Cardiovascular Outcome ◽

Expert Consensus ◽

Cardiovascular Outcome Trials ◽

Download Full-text

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial

Diabetes and Vascular Disease Research ◽

10.1177/1479164112475102 ◽

2013 ◽

Vol 10 (4) ◽

pp. 289-301 ◽

Author(s):

Julio Rosenstock ◽

Nikolaus Marx ◽

Steven E Kahn ◽

Bernard Zinman ◽

John J Kastelein ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Outcome ◽

Active Comparator ◽

Cardiovascular Outcome Trials

Download Full-text